Sheng Yao
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 56
- Cancer Immunotherapy and Biomarkers 33
- CAR-T cell therapy research 23
- Immunology 39
- Immunotherapy and Immune Responses 25
- Immune Cell Function and Interaction 16
- Co-authors
- Lieping ChenYuwen ZhuHaiying XuFrank WürthnerSarah J. FliesGefeng ZhuAndrew S. FliesChunping Tang
- Journals
- Journal of Clinical Oncology (10 papers)International Journal of Molecular Sciences (9 papers)Journal of Natural Products (9 papers)Blood (6 papers)Fitoterapia (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Sheng Yao
193 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Immunology 2.6k
- Oncology 3.1k
- Cancer Research 528
- Molecular Biology 1.9k
- Biomaterials 316
Countries citing papers authored by Sheng Yao
This map shows the geographic impact of Sheng Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Yao more than expected).
Fields of papers citing papers by Sheng Yao
This network shows the impact of papers produced by Sheng Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Yao. The network helps show where Sheng Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 33 | |
| 13 | 2020 | 33 | |
| 14 | Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma | 2020 | 1 |
| 15 | 2018 | 56 | |
| 16 | Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer Hit paper breakdown → | 2015 | 643 |
| 17 | 2014 | 316 | |
| 18 | Research on Coordination Countermeasures in Product Servitization Supply Chain Based on Service Capacity | 2011 | 1 |
| 19 | 2010 | 266 | |
| 20 | 2008 | 68 |
About Sheng Yao
Sheng Yao is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Biotechnology, having authored 204 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (33 papers), Natural product bioactivities and synthesis (29 papers), Immunotherapy and Immune Responses (25 papers), CAR-T cell therapy research (23 papers), Sesquiterpenes and Asteraceae Studies (18 papers), Phytochemistry and Biological Activities (17 papers), Immune Cell Function and Interaction (16 papers) and Biological Activity of Diterpenoids and Biflavonoids (10 papers). The work is most often cited by research in Immunology (2.6k citations), Oncology (3.1k citations), Cancer Research (528 citations), Molecular Biology (1.9k citations) and Biomaterials (316 citations). Sheng Yao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lieping Chen, Yuwen Zhu, Haiying Xu, Frank Würthner, Sarah J. Flies, Gefeng Zhu, Andrew S. Flies, Chunping Tang, Yang Ye and Janis M. Taube. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences, Journal of Natural Products, Blood and Fitoterapia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.